Clinical Analysis Of The Efficacy Of125-Iodine Particles Combined With Biliary Stent Implantation In The Treatment Of Malignant Obstructive Jaundice

Objective:To research and investigate the clinical efficacy of125-lodine particles combined with biliary stent implantation to treat malignant obstructive jaundice.Methods:Collected41malignant obstructive jaundice patients in our department between June2011and June2013.19patients treated by biliary stenting, as the control group;22patients using125-iodine particles combined biliary stent implantation, as the observation group. Both groups were treated by percutaneous transhepatic cholangial drainage (PTCD) and biliary stenting.Results:In addition to the1cases to be dead within4weeks, the rest40patients were available for efficacy evaluation. Average biliary stent’s unobstructed time of observation group and control group were (8.7±0.7) months and (6.2±0.4) months; the difference between the biliary stent’s unobstructed time of the two groups was statistically significant (p<0.05). The mean survival time was (11.4±0.8) months and (8.7±0.5) months; differences between the two groups in survival time were statistically significance (p<0.05). The recent therapeutic effect and complications of the two groups were no significant difference, but there are significant differences (p<0.05) in long-term effect.Conclusion:Compared with the control group, the observer group’s postoperative survival time and biliary recanalization time are obviously extended, so the further clinical studies in the latter treatment of malignant obstructive jaundice is very worthwhile.